Partners in Progress: Our Monthly Giving Program
Introducing Our Monthly Giving Program
by Despina Dinca

You can now become a:


💙 Hope Partner * £10/month
🔬 Research Champion * £25/month. 

 

Join our new monthly giving program, Partners in Progress: 

https://www.goodhub.com/go/partners-in-progress. 

 

The Hope Partner's contributions will help us maintain the connections to keep our community informed and supported. 

 

The Research Champion’s contributions ensure that we can continue to fund new & relevant future research. 

 

You will receive regular updates and our quarterly newsletter, NA News, featuring research developments, patient stories, and community news that keep you connected to the impact of your gift. 

 

Whether you're connected to our community through personal experience or simply believe in our mission, your regular support helps us be there for everyone who needs us. 

 

Important note for US donors: If you're based in the United States, we encourage you to donate through NA Advocacy USA’s website, to take advantage of tax-deductible benefits. NA Advocacy USA is a registered 501(c)(3) nonprofit, meaning your contributions are tax-deductible under US law.

 

UK and international donors outside the US can support us directly through https://www.goodhub.com/go/partners-in-progress. UK donors can also opt to Gift Aid the donation, which brings the charity an extra 25% at no cost for the donor.

 

Both organisations share the same mission and work closely together to support our global community. Together, we're searching for clues to a cure, and every gift brings us closer. Join us in this journey and become part of a community that's making real progress, one month at a time. 

 

With approximately 3,000 cases worldwide, our community is small but mighty, and every contribution makes a tangible difference. 

 

Partners in Progress new monthly program - Become a Hope Partner from £10 per month Partners in Progress new monthly program - Become a Research Champion from £25 per month

LikeLike (1) | Facebook Twitter LinkedIn
Related Articles